Estrogen-mediated mechanisms of stress susceptibility
雌激素介导的应激敏感性机制
基本信息
- 批准号:10064640
- 负责人:
- 金额:$ 40.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-16 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAmygdaloid structureAnhedoniaAutomobile DrivingBehaviorBehavioralBindingBlood PressureBrainBrain regionCardiacCardiovascular DiseasesCardiovascular systemConflict (Psychology)Corticotropin-Releasing HormoneDataDepressed moodDepressive disorderDevelopmentElectrophysiology (science)Estrogen Receptor betaEstrogen ReceptorsEstrogen ReplacementsEstrogensExhibitsExposure toFemaleFrightFunctional disorderGene TransferGenesGenetic TranscriptionGoalsImpairmentIncidenceMajor Depressive DisorderMeasuresMediatingMediator of activation proteinMenopauseMental DepressionMessenger RNAMicrodialysisModelingMood DisordersMyocardial dysfunctionNegative ValenceNeuromodulatorNeuronsNeuropeptidesNeurosecretory SystemsOvarian hormonePathologyPathway interactionsPeptidesPeriodicityPhysiologicalPlayPopulationPredispositionPubertyRattusReceptor ActivationRecording of previous eventsRegulationResponse ElementsRestRiskRisk FactorsRodentRoleSeriesSex DifferencesSignal TransductionSiteStartle ReactionStressSucroseSwimmingSympathetic Nervous SystemTelemetryTestingTimeTranslatingVirusWomanWomen&aposs Groupawakebasebiological adaptation to stresscomorbiditydepressive symptomsestrogenicin vivoindexingknock-downlocus ceruleus structuremalemenneural circuitneurochemistryneuromechanismnovelpreferencereceptorrelease factorresponsesexsmall hairpin RNAsocialsocial defeatsocial stressstress related disorderstress resilience
项目摘要
Project Summary
Women are twice as likely as men to suffer from stress-related affective disorders, and as a result, are also at
a greater risk of developing comorbid cardiovascular disease. This proposal investigates the estrogen (E)-
mediated neural mechanisms that we suggest are initiated in the central amygdala (CeA) to promote innate
stress vulnerability to both the emergence of negative valence and exaggerated cardiac sympathetic activation.
The proposed series of studies relies on the use of a witness stress paradigm whereby a male or female
rodent is located in a protected region of a dominant resident's cage and witnesses a social conflict between
the resident and a smaller male intruder. Following stress exposure, females with either intact ovarian
hormones, or ovariectomized with E replacement (OVX+E) exhibit negative valence (decreased sucrose
preference, increased burying) and exaggerated cardiac sympathetic levels (elevated resting blood pressure)
while OVX with vehicle replacement (OVX+V) and intact males are resilient, making this model ideal to study
the role of estrogen on increased stress susceptibility. Aim 1 expands upon preliminary data that support the
hypothesis that ovarian hormones, in particular E, exacerbate stress susceptibility. These studies will identify
sex differences and estrogenic effects on behavioral and sympathetic indices of stress-related pathology. Aim
2 utilizes direct intra-CeA administration of an E receptor (ER) agonist (DPN) or antagonist (PHTPP), to
activate or block, respectively, the ERs in the CeA. We hypothesize that inhibiting the ER in this brain region
will enhance stress resiliency in the innate susceptible (intact-cycling) and induced susceptible (OVX+E)
female groups, while activating the receptor will promote vulnerability in the induced resilient group (OVX). One
known effect of E is its ability to increase the stress-related neuropeptide corticotropin-releasing factor (CRF), a
peptide that is abundant in the CeA and is capable of inducing enhanced behavioral and sympathetic fear
responses. Our data indicate that intact females exhibit increased CRF in the CeA, but only if they have a
history of stress exposure. Therefore, Aim 2 will also identify if these ER treatments affect CRF expression in
the CeA. Finally, Aim 3 will use virus-mediated gene transfer to reduce CRF levels in the CeA to determine
whether the susceptibility-enhancing effects of the E are dependent upon CRF. Moreover, using in vivo
microdialysis, studies in Aim 3 will identify whether increased CRF in the CeA has consequences on the major
stress sensitive target the locus coeruleus (LC). CRF release and neuronal activity will be measured in the LC
during stress/control and will identify if intact females exhibit increased CRF release in the LC and whether this
translates to elevated activity. The ability of shRNA CRF knockdown in the CeA to affect LC activity and CRF
release will also be assessed. Together, these studies will provide evidence of a targeted mechanism
increasing susceptibility to affective disorders and comorbid cardiac dysfunction in females. These studies
propose a novel and “translatable” pathway by which E may regulate innate stress vulnerability in women.
项目概要
女性患与压力相关的情感障碍的可能性是男性的两倍,因此,她们也处于
合并心血管疾病的风险更大 该提案研究了雌激素 (E)-。
我们建议在中央杏仁核 (CeA) 中启动介导的神经机制,以促进先天性
应激易受负价的出现和过度的心脏交感神经激活的影响。
拟议的一系列研究依赖于使用证人压力范式,其中男性或女性
啮齿动物位于主要居民笼子的保护区内,目睹了之间的社会冲突
在压力暴露后,居民和较小的雄性入侵者的卵巢都完好无损。
激素或用 E 替代 (OVX+E) 切除卵巢的患者表现出负价(蔗糖减少)
偏好、增加埋葬)和夸大的心脏交感神经水平(静息血压升高)
而带有车辆更换的 OVX (OVX+V) 和完整的雄性具有弹性,使该模型成为研究的理想选择
目标 1 扩展了支持雌激素对压力敏感性增加的初步数据。
假设卵巢激素,特别是 E,会加剧应激敏感性,这些研究将确定这一点。
性别差异和雌激素对压力相关病理学的行为和交感指数的影响。
2 利用 E 受体 (ER) 激动剂 (DPN) 或拮抗剂 (PHTPP) 直接在 CeA 内给药,
分别激活或阻断 CeA 中的 ER,我们发现抑制该大脑区域的 ER。
将增强先天易感性(完整循环)和诱导易感性(OVX+E)的应激恢复能力
女性群体,同时激活受体将促进诱导弹性群体(OVX)的脆弱性。
E 的已知作用是它能够增加与压力相关的神经肽促肾上腺皮质激素释放因子 (CRF),这是一种
CeA 中丰富的肽,能够诱导增强的行为和交感恐惧
我们的数据表明,完整的雌性在 CeA 中表现出增加的 CRF,但前提是它们具有
因此,目标 2 还将确定这些 ER 治疗是否影响 CRF 表达。
最后,Aim 3 将使用病毒介导的基因转移来降低 CeA 中的 CRF 水平,以确定
E 的易感性增强作用是否取决于 CRF。
微透析,目标 3 中的研究将确定 CeA 中 CRF 的增加是否对主要
应激敏感靶标蓝斑 (LC) 将在 LC 中测量 CRF 释放和神经元活动。
在应激/控制期间,将确定完整雌性是否在 LC 中表现出增加的 CRF 释放,以及这是否
CeA 中 shRNA CRF 敲低影响 LC 活性和 CRF 的能力。
释放也将被评估,这些研究将提供有针对性的机制的证据。
这些研究增加了女性对情感障碍和合并心功能障碍的易感性。
提出了一种新颖且“可翻译”的途径,E可以通过该途径调节女性先天的压力脆弱性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Kathleen Wood其他文献
Susan Kathleen Wood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan Kathleen Wood', 18)}}的其他基金
Neural regulation of susceptibility to hyperarousal
过度觉醒易感性的神经调节
- 批准号:
10485538 - 财政年份:2022
- 资助金额:
$ 40.23万 - 项目类别:
Estrogen-mediated mechanisms of stress susceptibility
雌激素介导的应激敏感性机制
- 批准号:
10318159 - 财政年份:2018
- 资助金额:
$ 40.23万 - 项目类别:
Estrogen-mediated mechanisms of stress susceptibility
雌激素介导的应激敏感性机制
- 批准号:
9523126 - 财政年份:2018
- 资助金额:
$ 40.23万 - 项目类别:
A new Chinese herb-derived selective Toll-like receptor antagonist (Project 1)
一种新型中药选择性Toll样受体拮抗剂(项目1)
- 批准号:
8531297 - 财政年份:2013
- 资助金额:
$ 40.23万 - 项目类别:
相似国自然基金
FOXD1-SFRP2及其特异性激动剂在骨关节炎中的功能及作用机制探究
- 批准号:82372438
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TRPV4/SKCa信号轴在AMPK激动剂抑制微小动脉舒张作用中的机制研究
- 批准号:82304584
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向STING激动剂和TREM2抑制剂增强PD-1抑制剂对胰腺癌的抗肿瘤作用研究
- 批准号:82303740
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Alcohol-induced epigenetic reprogramming of PPAR-α affects allopregnanolone biosynthesis
酒精诱导的 PPAR-α 表观遗传重编程影响异孕酮生物合成
- 批准号:
10658534 - 财政年份:2023
- 资助金额:
$ 40.23万 - 项目类别:
Role of glucagon-like peptide-1 signaling in mediating sensory-specific satiety
胰高血糖素样肽-1 信号传导在介导感觉特异性饱腹感中的作用
- 批准号:
10750216 - 财政年份:2023
- 资助金额:
$ 40.23万 - 项目类别:
PPARdelta receptors and alcohol use phenotypes
PPARδ 受体和饮酒表型
- 批准号:
10682348 - 财政年份:2023
- 资助金额:
$ 40.23万 - 项目类别:
Neuropeptide Y1 Receptor-Expressing Neurons in the Lateral Parabrachial Nucleus in Neuropathic Pain
神经性疼痛中臂旁核外侧核表达神经肽 Y1 受体的神经元
- 批准号:
10635473 - 财政年份:2023
- 资助金额:
$ 40.23万 - 项目类别:
Sickle cell disease gut dysbiosis effects on CNS pain processing
镰状细胞病肠道菌群失调对中枢神经系统疼痛处理的影响
- 批准号:
10747045 - 财政年份:2023
- 资助金额:
$ 40.23万 - 项目类别: